Project/Area Number |
17592123
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Kurume University |
Principal Investigator |
IWAMOTO Osamu Kurume University, Lecture, 医学部, 講師 (80247527)
|
Co-Investigator(Kenkyū-buntansha) |
KUSUKAWA Jingo Kurume University, Professor, 医学部, 教授 (30258412)
KOGA Chihiro Kurume University, Associate Professor, 医学部, 助教授 (80258417)
|
Project Period (FY) |
2005 – 2006
|
Project Status |
Completed (Fiscal Year 2006)
|
Budget Amount *help |
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 2006: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2005: ¥1,700,000 (Direct Cost: ¥1,700,000)
|
Keywords | cancer / virus / immunology |
Research Abstract |
The summary of experimental results was as follows : 1. HSV-1 antigen expression in 102 oral squamous cell carcinoma (SCC) cases was immunohistochemically evaluated using anti-rabbit polyclonal antibody, and the positive rate was approximately 53% (HSV-1-positive group). Furthermore, the expression (330 bp) was confirmed at the gene level (RT-PCR method). 2. Retrospective comparison of HSV-1-positive and -negative groups showed that the rate of cervical lymph node metastasis was significantly lower in the former compared to the latter (p<0.01). Furthermore, the 5-year cumulative survival rate was higher in the positive group (95% vs. 83%, respectively). 3. Neutralizing antibody titers and serum IgG were significantly higher in the HSV-1-positive group (p<0.01). 4. The HSV-1-positive group showed marked infiltration of CD8-positive T-lymphocytes in the cancerous tissue. These results suggested that HSV-1 occurring in cancers increased immunological function around cancers, which inhibited lymph node metastasis. To elucidate the expression pathway of HSV-1 in oral cancers, we are producing an oral cancer model using HSV-1-latently infected Syrian hamsters.
|